Hypoglycaemia downregulates endotoxin-induced production of tumour necrosis factor-α, but does not affect IL-1β, IL-6, or IL-10

被引:14
作者
de Galan, BE
Netea, MG
Smits, P
van der Meer, JWM
机构
[1] Univ Nijmegen, Med Ctr, Dept Gen Internal Med, Nijmegen, Netherlands
[2] Univ Nijmegen, Med Ctr, Dept Pharmacol Toxicol, Nijmegen, Netherlands
关键词
diabetes mellitus; humans; hypoglycaemia; insulin; TNF alpha;
D O I
10.1016/S1043-4666(03)00113-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aim of the present study was to investigate the effect of hypoglycaemia on the production capacity of the proinflammatory cytokines tumour necrosis factor-alpha (TNFalpha) and interleukin-1beta (IL-1beta) in subjects with and without diabetes. Hyperinsulinaemic (360 pmol m(-2) min(-1)) stepped hypoglycaemic (5.0-3.5-2.5 mmol 1(-1)) glucose clamps were performed in eight diabetic patients and in six non-diabetic subjects, and hyperinsulinaemic normoglycaemia (5.0 mmol 1(-1)) control experiments were performed in four nondiabetic subjects. Circulating levels of cytokines and endotoxin-induced production of TNFalpha, IL-1beta IL-6, and IL-10 were assessed. The effects of insulin and adrenaline were measured in separate in vitro experiments. In non-diabetic subjects, hypoglycaernia downregulated the production capacity of TNFalpha in a concentration-dependent fashion (P = 0.007), but not of IL-1beta, IL-6, or IL-10. Compared to controls, the production capacity of TNFalpha in diabetic patients was already suppressed at normoglycaernia (P = 0.02) and only fell in response to hypoglycaemic nadir (P = 0.04). The downregulation of TNFalpha could not be explained by increased insulin or adrenaline levels. We conclude that hypoglycaemia specifically downregulates TNFalpha production capacity. Diabetic patients already have a suppressed TNFalpha production capacity at non-hypoglycaemic levels. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:71 / 76
页数:6
相关论文
共 29 条
[21]   Epinephrine inhibits endotoxin-induced IL-1β production:: roles of tumor necrosis factor-α and IL-10 [J].
Van der Poll, T ;
Lowry, SF .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1997, 273 (06) :R1885-R1890
[22]   Elective orthopedic surgery, a model for the study of cytokine activation and regulation [J].
van Deuren, M ;
Twickler, TB ;
Malefyt, MCD ;
van Beem, H ;
van der Ven-Jongekrijg, J ;
Verschueren, CMM ;
van der Meer, JWM .
CYTOKINE, 1998, 10 (11) :897-903
[23]   DETERMINATION OF CATECHOLAMINES IN HUMAN-PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY - COMPARISON BETWEEN A NEW METHOD WITH FLUORESCENCE DETECTION AND AN ESTABLISHED METHOD WITH ELECTROCHEMICAL DETECTION [J].
VANDERHOORN, FAJ ;
BOOMSMA, F ;
TVELD, AJMI ;
SCHALEKAMP, MADH .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1989, 487 (01) :17-28
[24]   Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: Sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13 [J].
vanderPoll, T ;
Malefyt, RD ;
Coyle, SM ;
Lowry, SF .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (01) :118-122
[25]   Epinephrine attenuates down-regulation of monocyte tumor necrosis factor receptors during human endotoxemia [J].
vanderPoll, T ;
Calvano, SE ;
Kumar, A ;
Coyle, SM ;
Lowry, SF .
JOURNAL OF LEUKOCYTE BIOLOGY, 1997, 61 (02) :156-160
[26]   Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia [J].
vanderPoll, T ;
Coyle, SM ;
Barbosa, K ;
Braxton, CC ;
Lowry, SF .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (03) :713-719
[27]  
VANDEUREN M, 1993, J INT FED CLIN CHEM, V5, P216
[28]  
Zellweger R, 1996, J IMMUNOL, V157, P5748
[29]  
ZIEGLERHEITBROCK HWL, 1995, J INFLAMM, V45, P13